Medicine & Life Sciences
Reverse Transcriptase Inhibitors
100%
Anti-Infective Agents
93%
HIV-1
74%
HIV
70%
Chikungunya virus
43%
Viruses
39%
Triazines
36%
Antiviral Agents
31%
Nanoparticles
27%
Immunoglobulin G
24%
Coronavirus Spike Glycoproteins
24%
Mutation
23%
Genotype
23%
Guinea-Bissau
22%
Binding Sites
21%
Immunoglobulin M
21%
Structure-Activity Relationship
20%
Dengue Virus
19%
Antibodies
19%
Viral Structural Proteins
19%
Anti-HIV Agents
19%
Gels
18%
Severe Acute Respiratory Syndrome
18%
Microcephaly
18%
Coronavirus
18%
Peru
17%
Pharmaceutical Preparations
17%
Asian Americans
17%
Dengue
17%
Microbiota
16%
Macaca
15%
Disease Outbreaks
15%
Routine Diagnostic Tests
14%
Bacterial Vaginosis
13%
Netherlands
13%
Monoclonal Antibodies
13%
Libraries
13%
Ligands
12%
Nucleocapsid
12%
Neutralizing Antibodies
12%
Neutralization Tests
12%
Biomarkers
12%
Membrane Proteins
11%
Fluorobenzenes
11%
Cross-Sectional Studies
11%
Enzyme-Linked Immunosorbent Assay
11%
Proteins
10%
Amination
9%
Cytokines
9%
Lactobacillus
9%
Chemical Compounds
Triazines
36%
Reverse Transcriptase Inhibitors
35%
Viruses
28%
Antiviral Agents
19%
Cytotoxicity
15%
Anti-Infective Agents
14%
Interleukin-1
14%
Liposomes
14%
Dimers
13%
Nanoparticles
9%
Pharmaceutical Preparations
9%
Cytokines
6%
Diamines
5%
Interleukins
5%
Antibodies
5%
Biomarkers
5%
Interleukin-12
5%